Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial-Reference-Cited by-同舟云学术

Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial

Published:2000-11 Issue:11 Volume:85 Page:4118-4124
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Black Dennis M.,Thompson Desmond E.,Bauer Douglas C.,Ensrud Kris,Musliner Thomas,Hochberg Marc C.,Nevitt Michael C.,Suryawanshi Shailaja,Cummings Steven R.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 520 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials;Drug Safety;2024-09-03

2. Cost-Effectiveness of Artificial Intelligence–Based Opportunistic Compression Fracture Screening of Existing Radiographs;Journal of the American College of Radiology;2024-09

3. The cost-effectiveness of a co-managed care model for elderly hip fracture patients in China: a modelling study;The Lancet Regional Health - Western Pacific;2024-08

4. [Translated article] Evaluation, differential diagnosis and treatment of vertebral osteoporosis: How to avoid the occurrence of new fractures;Revista Española de Cirugía Ortopédica y Traumatología;2024-08

5. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024;Journal of Bone and Mineral Research;2024-07-29